References
- Kawano F, Tsukamoto A, Satoh M, Sanada I, Shido T, Miura K, et al. Non-secretory primary plasma cell leukemia with hyperammonemia. Jap J Clin Hematol 1991; 32: 399–403
- Tsunoda S, Sasaki R, Miwa A, Sakurabayashi I, Miura Y. Coma, hyperviscosity syndrome, hyperammonemia and myelofibrosis in a patient with IgG, λtype multiple myeloma. Jap J Clin Hematol 1989; 30: 361–365
- Ohmoto A, Kohno M, Yasukawa K, Matsuyama R. Massive ascites as an initial sign, plasmacytoma of the cervical supine, and hyperammonemic consciousness disturbance in a patient with biclonal type multiple myeloma. Jap J Clin Hematol 1996; 37: 346–351
- Kozuka T, Fukuda S, Imai T, Sezaki T. Clinical significance of a multiple myeloma cell line, derived from a case associated with hyperammonemia. Jap J Clin Hematol 2000; 41: 1220–1225
- Fujii S, Fukuda S, Sezaki T, Murakami M. Clinicopathological study of multiple myeloma associated with hyperammonemia. Jap J Clin Hematol 1998; 39: 27–33
- Keller D R, Keller K. Hyperammonemic encephalopathy in multiple myeloma. Am J Hematol 1998; 57: 264–265
- Holahan J R. Hyperammonemia: elevated ammonia levels in multiple myeloma. Am J Med 2004; 116: 210–211
- Kwan L, Wang C. Hyperammonemic encephalopathy in multiple myeloma. N Engl J Med 2002; 21: 1674–1675
- Matsuo Y, Drexler H G, Nishizaki C, Harashima A, Fukuda S, Kozuka T, et al. Human bone marrow stroma-dependent cell line MOLP-5 derived from a patient in leukemic phase of multiple myeloma. Br J Haematol 2000; 109: 54–63
- Caminal L, Castellanos E, Mateos V, Astudillo A, Mareno C, Dieguez M A. Hyperammonaemic encephalopathy as the presenting feature of IgD multiple myeloma. J Intern Med 1991; 233: 277–279
- Matsuzaki H, Uchida M, Yoshimura K, Yoshida M, Akahoshi Y, Okazaki K, et al. Hyperammonemia in multiple myeloma. Acta Haematol 1990; 84: 130–134
- Takimoto Y, Imanaka F, Hayashi Y, Morioka S. A patient with ammonia-producing multiple myeloma showing hyperammonemic encephalopathy. Leukemia 1996; 10: 918–919
- Perez Retortillo J A, Marco F, Amutio E, Conde E, Iriondo A, Zubizarreta A. Hyperammonemic encephalopathy in multiple myeloma. Haematologica 1998; 83: 956–957
- Pellet-Deceunynck C, Barille S, Jego G, Puthier D, Robillard N, Pineau D, et al. The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma. Leukemia 1998; 12: 1977–1982
- Talamo G, Cavallo F, Zangari M, Barlogie B, Lee C K, Pineda-Roman M, et al. Hyperammonemia and encephalopathy in patients with multiple myeloma. Am J Hematol 2007; 82: 414–415